CASE STUDY
Cardiovascular
Clamphix: Innovation in Sternal Stabilization
Medical Condition/Clinical Need
A select group of cardiothoracic surgeons had requested the need for a more effective way to perform cardiothoracic surgery with a minimally invasive impact on the patient. These surgeons collaborated with Phoenix S.r.l. to create the Clamphix Sternal Stabilization Device. This device will be utilized in thoracic surgery, ensuring effective sternal closure that is essential for patient recovery and minimizing complications.
The Challenge
Traditional metal-based systems, although effective, can present limitations such as increased weight, radiopacity, and long-term integration with bone.
The Design/Manufacturing Solution
Clamphix is an innovative single-use sternal closure device developed by Phoenix S.r.l., made from biocompatible Peek OPTIMA polymer. It consists of a connector with two intercostal hooks—one fixed and one sliding with small teeth for secure aeration of the sternum.
Some Key Advantages of this device are:
- Biocompatibility and Safety: Does not integrate with bone, allowing for easier removal if needed. Non-carcinogenic and radiotransparent, enabling unimpeded imaging via CT and MRI.
- Lightweight Design: Compared to steel or titanium alternatives, Clamphix reduces the overall weight of implanted material, lessening surgical trauma.
- Faster Recovery: Semi-rigid compression helps reduce immobilization time and accelerates healing.
Surgical Technique Overview
- Create intercostal access routes through external ligaments and muscles.
- Insert the fixed hook laterally through the first access point.
- Reduce staple size and position the movable hook into the opposing access route.
- Verify placement and security using the dedicated applicator.
- Cut off any excess connector material using the specific cutter.
Results
Clamphix has proven to be an effective and minimally invasive alternative to traditional sternal closure systems, prioritizing both patient comfort and surgical efficiency.